GlassScriptPhysician profile
Ha Jimmy Chim
NPI 1255534871
$354,737.02
in general payments reported to CMS, 2019-2025
31 companies · $112K in 2025
The $112K reported for 2025 was more than what 99% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,494 · 2020: $585 · 2021: $3,472 · 2022: $11K · 2023: $97K · 2024: $126K · 2025: $112K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $306K · Travel and Lodging: $18K · Food and Beverage: $6,832 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Entertainment: $92.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $306,225.00 |
| Travel and Lodging | $18,022.21 |
| Food and Beverage | $6,832.45 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Entertainment | $92.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $327,955.78 | 2022-2025 | |
| Merz North America, INC. | $8,503.32 | 2022-2023 | Xeomin |
| Medela LLC | $4,475.80 | 2022-2024 | Dominant Flex Portable, Invia Motion Endure |
| Allergan, INC. | $4,153.54 | 2019-2021 | |
| Smith+Nephew, INC. | $2,916.61 | 2019-2025 | Grafix Pl, Stravix Pl, Grafix |
| Stryker Corporation | $2,798.26 | 2019-2025 | Hoffmann |
| Mentor Worldwide LLC | $907.87 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Depuy Synthes Sales INC. | $365.40 | 2019-2022 | |
| Access Pro Medical, LLC | $323.46 | 2025 | Matriderm |
| Aroa Biosurgery Incorporated | $268.80 | 2024-2025 | |
| Coopersurgical, INC. | $255.38 | 2020-2025 | Insorb, Cook |
| Tei Medical INC. | $214.61 | 2019 | |
| Davol INC. | $212.94 | 2024-2025 | Phasix Mesh, Arista |
| Solventum Corporation | $208.51 | 2025 | Prevena, V.A.C.Instill |
| Axogen | $191.12 | 2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $150.03 | 2020 | |
| Polynovo North America LLC | $143.56 | 2020 | |
| Abbvie INC. | $139.13 | 2023-2024 | Natrelle Saline-Filled Breast Implants |
| Organogenesis INC. | $117.10 | 2019 | |
| Kerecis Limited | $91.18 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Solta Medical, A Division of Bausch Health US, LLC | $51.31 | 2019 | |
| Tela Bio, INC. | $50.32 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Biocircuit Technologies INC | $47.15 | 2025 | Nerve Tape |
| Sientra, INC. | $39.58 | 2020-2021 | |
| Innovation Technologies INC | $33.52 | 2021 | |
| Kci USA, INC. | $30.32 | 2020-2023 | V.A.C. Dermatac |
| Acera Surgical, INC. | $24.79 | 2025 | Restrata Wound Matrix |
| Ethicon US, LLC | $21.18 | 2025 | Dermabond Prineo, Stratafix |
| Pacira Pharmaceuticals Incorporated | $20.24 | 2022 | |
| Novartis Pharmaceuticals Corporation | $13.18 | 2022 | |
| Baxter Healthcare | $13.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ha Chim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.